Table 6.
Doses and timing of sulforaphane (SFN) administrations in the first healthy volunteer enrolled (HV1).
| Lower Dose | |
|---|---|
| Dose/Day | Administration Timing |
| - | No assumption (T0) |
| 12.6 mg | Day 1 (T1) |
| 25.2 mg | Day 2–3 (T2) |
| 25.2 mg | 7 days assumption (T3) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.